Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
11/22/2012 | WO2012075457A3 Method and system for capture and use of intact vesicles on electrodeposited hydrophobically modified biopolymer films |
11/22/2012 | WO2011146514A3 Rapid isolation of monoclonal antibodies from animals |
11/22/2012 | WO2011088338A3 Methods for improving skin quality |
11/22/2012 | US20120297502 Method for improving plant tolerance to environmental stress |
11/22/2012 | US20120297500 Precise breeding - low acrylamide foods |
11/22/2012 | US20120296403 Methods and compounds for muscle growth |
11/22/2012 | US20120296189 Methods of Collecting and Analyzing Samples |
11/22/2012 | US20120296179 Analyte concentration detection devices and methods |
11/22/2012 | US20120296145 Methods for monitoring ionic liquids using vibrational spectroscopy |
11/22/2012 | US20120296067 Compound capable of binding to naturally occurring denatured protein, and method for screening for the compound |
11/22/2012 | US20120296054 Method for quantitative analysis of styrene microblock content |
11/22/2012 | US20120295990 Insulin Receptor Substrate 1 (IRS1) Protein SRM/MRM Assay |
11/22/2012 | US20120295950 Rbp4 in insulin sensitivity/resistance, diabetes, and obesity |
11/22/2012 | US20120295932 Method for the treatment of cancer |
11/22/2012 | US20120295890 Glycosaminoglycan inhibitors |
11/22/2012 | US20120295878 Method for the treatment of cancer |
11/22/2012 | US20120295874 Coferons and methods of making and using them |
11/22/2012 | US20120295844 Use of aprotinin for treating parasitic infections and prognosing bovine trypanotolerance |
11/22/2012 | US20120295818 Method of multi pathogen detection |
11/22/2012 | US20120295817 Aza-benzazolium Containing Cyanine Dyes |
11/22/2012 | US20120295814 CA-125 Immune Complexes as Biomarkers of Ovarian Cancer |
11/22/2012 | US20120295812 Method for extracting staphylococcus aureus antigen, reagent for extracting staphylococcus aureus antigen, and method for assessing staphyloccoccus aureus |
11/22/2012 | US20120295808 Solid Support Assay Systems and Methods Utilizing Non-Standard Bases |
11/22/2012 | US20120295802 Methods and compositions for cancer treatment relating to brca1 brct domain recognition of phosphorylated bach1 |
11/22/2012 | US20120295797 Methods for diagnosis and prognosis of pulmonary hypertension |
11/22/2012 | US20120295369 Method for determination of aggregates |
11/22/2012 | US20120295368 Kits for detecting target material and methods of detecting target material using the kits |
11/22/2012 | US20120295367 Composition and method for analysis of target analytes |
11/22/2012 | US20120295362 Urinalyisis test for synthetic canabanoids |
11/22/2012 | US20120295350 Prospective Identification and Characterization of Breast Cancer Stem Cells |
11/22/2012 | US20120295327 Targeted Therapeutic Proteins |
11/22/2012 | US20120295295 Detecting isomers using differential derivatization mass spectrometry |
11/22/2012 | US20120295291 Method for Determining the Risk of Clopidogrel Resistance |
11/22/2012 | US20120295289 Device and method for culturing cells |
11/22/2012 | US20120295288 Serological marker for detecting pancreatic cancer and a method for using the serological marker |
11/22/2012 | US20120295287 Preparing hapten-specific antibodies and their application for immunodiagnostics and research |
11/22/2012 | US20120295286 Methods for the Diagnosis, Prognosis and Monitoring of Cancer Therapy Using BP1 |
11/22/2012 | US20120295285 Ordered Assembly of Membrane Proteins During Differentiation of Erythroblasts |
11/22/2012 | US20120295282 Methods of diagnosing or treating prostate cancer using the erg gene, alone or in combination with other over or under expressed genes in prostate cancer |
11/22/2012 | US20120295281 Specific salivary biomarkers for risk detection, early diagnosis, prognosis and monitoring of alzheimer's and parkinson's diseases |
11/22/2012 | US20120295280 Citrullinated peptides for diagnosing and prognosing rheumatoid arthritis |
11/22/2012 | US20120295279 Pretreatment solution for immunohistochemical staining and condensed solution thereof |
11/22/2012 | US20120295277 Device and method for detecting the presence of hemoglobin in a biological sample |
11/22/2012 | US20120295275 Monoclonal Antibodies and Uses Thereof |
11/22/2012 | US20120295274 Reporter vector presenting extracellular binding capacity to metallic compounds |
11/22/2012 | US20120295273 N-acetylhexosamine-containing n-glycans in glycoprotein products |
11/22/2012 | US20120295272 Proinflammatory nucleic acids |
11/22/2012 | US20120295265 Systems and methods for enhanced scoda |
11/22/2012 | US20120295259 Methods for Determining the Likelihood of Survival and for Predicting Likelihood of Metastasis in Cancer Patients |
11/22/2012 | US20120295253 Dynamic Monitoring of Activation of Receptor Tyrosine Kinase (RTK) in Living Cells Using Real-Time Microelectronic Cell Sensing Technology |
11/22/2012 | US20120295250 Microchip, Measurement System and Method Using the Same, and Test Reagent to be Used for Microchip |
11/22/2012 | US20120294932 Prostate Carcinogenesis Predictor |
11/22/2012 | US20120294929 Method of diagnosing and treating cancer using b-catenin splice variants |
11/22/2012 | US20120294891 Materials and methods for detecting, preventing, and treating retroviral infection |
11/22/2012 | US20120294885 Toll-like receptor-7 and -8 modulatory 1h imidazoquinoline derived compounds |
11/22/2012 | US20120294883 Oligomeric receptor ligand pair member complexes |
11/22/2012 | US20120294874 Method for Producing T Cell Receptor-Like Monoclonal Antibodies and Uses Thereof |
11/22/2012 | US20120294871 Modulation of gpcr-mediated camp production through lrp6 and its therapeutic application |
11/22/2012 | US20120294870 Compositions and methods for diagnosis and treatment of tumors |
11/22/2012 | US20120294865 Integrin Alpha-2 Binding Agents and Use Thereof to Inhibit Cancer Cell Proliferation |
11/22/2012 | US20120294859 Cancer stem cell markers and uses thereof |
11/22/2012 | US20120294856 Compounds inhibiting cd95 signaling for the treatment of pancreatic cancer |
11/22/2012 | US20120294837 Methods of isolating and culturing mesenchymal stem cells |
11/22/2012 | US20120294807 Fluorescent compounds |
11/22/2012 | US20120294805 DNA regulatory element for the expression of transgenes in neurons of a subject and uses thereof |
11/22/2012 | US20120294804 Phenylethanolamine-based nmda receptor antagonists |
11/22/2012 | US20120294800 Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies |
11/22/2012 | US20120294799 Anti-tem1 antibodies and uses thereof |
11/22/2012 | US20120294796 Antibodies Reactive with B7-H3 and Uses Thereof |
11/22/2012 | US20120294767 Portable hemostasis analyzer |
11/22/2012 | US20120294762 Temporary Store |
11/22/2012 | US20120293183 Method and control unit for monitoring cable faults on a broadband lambda probe |
11/22/2012 | US20120291569 Instrumented Foam Pig |
11/22/2012 | US20120291535 Oil mist detector test rig |
11/22/2012 | US20120291532 Methods, Systems, And Apparatus To Determine A Clot Carryout Condition Upon Probe Retraction During Sample Aspiration And Dispensing |
11/22/2012 | US20120291529 Method for biodiesel blending detection based on fuel post-injection quantity evaluation |
11/22/2012 | US20120291523 Kit for assessing the fragrance intensity of a fabric care product |
11/22/2012 | US20120291521 Method and device for deriving the concentration of a gas dissolved in an electrical insulation oil |
11/22/2012 | US20120291517 Pre-calibrated replaceable sensor module for a breath alcohol testing device |
11/22/2012 | US20120291515 Sensor unit and measurement method |
11/22/2012 | DE102011076238A1 Anordnung und Verfahren zur optischen Analyse und spezifischen Isolierung von biologischen Proben Apparatus and method for optical analysis and specific isolation of biological samples |
11/22/2012 | DE102011076051A1 Magnetophoretische Analytselektion und -anreicherung Magnetophoretic Analytselektion and enrichment |
11/22/2012 | DE102011050550A1 Verfahren und Anordnung zur Quantifizierung von Untergruppen aus einer Mischpopulation von Zellen Method and arrangement for the quantification of subgroups from a mixed population of cells |
11/22/2012 | DE102011050493A1 Vorrichtung und Verfahren zur Detektion der Auslenkung elastischer Elemente Apparatus and method for detecting the deflection of elastic members |
11/22/2012 | DE102011050490A1 Force sensor i.e. high-resolution sensor, for measuring cell and microorganism force to observe movement of cell and microorganism of e.g. small animals, has pillar cross-section at upper end larger than cross-section at lower end |
11/22/2012 | CA2839865A1 Microbe detection via hybridizing magnetic relaxation nanosensors |
11/22/2012 | CA2836565A1 Diagnosis of respiratory tract infectious diseases using urine specimens |
11/22/2012 | CA2836562A1 Diagnosis of respiratory tract infectious disease using blood specimens |
11/22/2012 | CA2836448A1 Detecting, preventing, and treating bronchopulmonary dysplasia |
11/22/2012 | CA2836114A1 Method of detection of amino acid sequence and/or identification of peptides and proteins, by use of a new derivatization reagent and synthesis of 5-formyl-benzene-1,3-disulphonicacid as derivatization reagent |
11/22/2012 | CA2836103A1 Modification-dependent activity assays |
11/22/2012 | CA2836098A1 Hendra and nipah virus g glycoprotein immunogenic compositions |
11/22/2012 | CA2835806A1 Methods and compositions relating to platelet sensitivity |
11/22/2012 | CA2835798A1 Epha4 is a disease modifier in motor neuron disease |
11/22/2012 | CA2835477A1 Method for the diagnosis of early rheumatoid arthritis |
11/22/2012 | CA2835339A1 Signature for the diagnosis of cancer aggressiveness and genetic instability |
11/22/2012 | CA2835284A1 Methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patients |
11/22/2012 | CA2834783A1 Methods and compositions for detecting microbial production of water-immiscible compounds |
11/22/2012 | CA2834653A1 Rbm3 in bladder cancer |
11/22/2012 | CA2834572A1 Method, solvent formulation, and apparatus for the measurement of the salt content in petroleum fluids |